Top

Pharmaceutical Supply – Albuterol Sulfate Inhalation Aerosol

Active

Federal

Response Deadline08/11/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FORT LEWIS, WA, 98433-9500, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 5

subcontract

Response DeadlineAug 11

Submission deadline

Response Deadline

08/11/2026, 05:00:00 PM UTCin 4 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Supply of Albuterol Sulfate Inhalation Aerosol with HFA propellant, compliant with military packaging and labeling standards for delivery to DoD medical supply chain.

Similar Contracts

Same NAICS industry code

NAICS: 325412

New

Federal

SUPPLY AND DELIVERY OF MEDICAL SUPPLIES

Solicitation # 19RP3826Q0059

The U.S. Department of State through the U.S. Embassy Manila is soliciting quotations for the supply and delivery of medical supplies under solicitation number 19RP3826Q0059, with a NAICS code of 325412. Offerors must submit their proposals electronically by August 10, 2026, at 4:00 p.m. Philippine local time, using MS-Word 2007/2010, MS-Excel 2007/2010, or Adobe Acrobat PDF formats, with individual files not exceeding 10MB; larger submissions must be split into multiple emails each under the size limit. Proposals must be in English and include the completed SF-1449 form, Section I Pricing, Section 5 Representations and Certifications, and any additional requirements outlined in Section 3 of the solicitation. All offerors must be registered in the System for Award Management (SAM) prior to submission, as mandated by FAR 4.1102, and failure to register will result in non-responsibility determination. Questions regarding the solicitation must be submitted in writing to ManilaContracting@state.gov no later than July 17, 2026, at 4:00 p.m. Philippine local time. The government intends to award a contract to the responsible vendor submitting the lowest priced acceptable offer, potentially holding discussions only if necessary. No details on delivery schedules, inspection criteria, packaging specifications, or evaluation factors are provided in the available documentation.

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9402

The Department of War, through the Defense Health Agency, is soliciting quotes under RFQ HT9402-26-Q-9402 to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by 10 U.S.C. § 1074g and 32 CFR § 199.21. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine placement on the Uniform Formulary as generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary, with the goal of optimizing pharmaceutical procurement through Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements. Four newly approved drugs—Awiqli Flextouch (basal insulin), Cavhanza (BCR-ABL tyrosine kinase inhibitor for leukemia and lymphoma), Lipfendra (PCSK9 antilipidemic), and Trutakna (nephrology agent)—are scheduled for review at the November 2026 Pharmacy and Therapeutics Committee meeting, and industry responses will inform their inclusion or exclusion. Responses to the RFQ are due by August 27, 2026, with a pre-quotation teleconference scheduled for August 12, 2026, to clarify requirements. Clinical data submissions for evaluation must be sent via email to the designated point of contact by the deadline specified in Part 2.3.2. The solicitation, issued by the Defense Health Agency under NAICS code 325412, is managed from Aurora, Colorado, with performance centered in San Antonio, Texas. Primary contact is Julia Trang, with Stephanie Erpelding as secondary contact, and all submissions and inquiries must adhere to the instructions outlined in RFQ HT9402-26-Q-9402 to be considered valid.

Defense Health Agency

POSTED

DEADLINE

Department of War Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program

Solicitation # HT9402-26-Q-9401

The Department of War, through the Defense Health Agency, is soliciting quotations to support the establishment and maintenance of the Uniform Formulary for the Military Health System, as mandated by federal law and regulation. The process involves evaluating pharmaceutical agents for clinical and cost effectiveness to determine their placement on the formulary tiers—generic, formulary, Basic Core Formulary, Extended Core Formulary, or non-formulary—with the goal of optimizing patient access and managing expenditures. The solicitation includes the potential award of Uniform Formulary Blanket Purchase Agreements and Uniform Formulary Additional Discount Program Agreements contingent upon the Pharmacy and Therapeutics Committee’s recommendations. Two drug classes are under review for the November 2026 meeting: Atopy—Topical Agents including Anzupgo, Eucrisa, Opzelura, Vtama, and Zoryve; and Lung Cancer—METEX14, including Tabrecta and Tepmetko. The request for quotation, identified as HT9402-26-Q-9401, outlines detailed procedures, appendices for BPA and ADP, and key submission deadlines. Responses are required by October 1, 2026, with a mandatory pre-quotation teleconference scheduled for August 12, 2026. The solicitation is issued by the Defense Health Agency under the Department of Defense, with the primary point of contact located in Aurora, Colorado, and performance expected in Texas. Vendors must adhere strictly to the instructions provided in the RFQ to ensure eligibility for consideration under the uniform formulary program, which directly impacts pharmacy benefits for military personnel and their dependents.

Defense Health Agency

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply – Oral ContraceptivesThe contract calls for the manufacture and supply of FDA-approved oral contraceptive tablets containing Norethindrone and Ethinyl Estradiol, USP, meeting a minimum 36-month shelf life and adhering to current good manufacturing practices. The product must also comply with military preservation standards to ensure stability and integrity under field conditions. Production and packaging are required to align with cGMP regulations and the specific demands of the Department of Defense supply chain, with the intended delivery point being APO, ZIP 96543-4010. This is a subcontract opportunity issued under NAICS code 325412, targeting manufacturers capable of consistent, high-volume production for federal procurement. Responses must be submitted by August 11, 2026, following the solicitation issued by the Medical Supply Chain Pharm FSA, which operates under the Department of Defense. All parties must be prepared to meet stringent quality, documentation, and logistical requirements to fulfill military-grade distribution needs.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Fluorescein Sodium Ophthalmic StripsThe contract solicits the manufacture and delivery of Fluorescein Sodium Ophthalmic Strips that comply with FDA regulations and are packaged in sealed unit containers to meet strict military standards for packaging, labeling, and shelf-life. These strips are intended for ophthalmic use and must adhere to the Department of Defense’s specifications for quality, sterility, and longevity under operational conditions. The product will be delivered to Fort Drum, New York, with all packaging and documentation aligned to military logistics and traceability requirements. This is a subcontract issued under NAICS code 325412, which pertains to pharmaceutical preparation manufacturing, and was posted on August 5, 2026, with responses due by August 11, 2026. The contracting activity is managed by the Medical Supply Chain Pharm FSA under the Department of Defense, indicating this is part of a broader defense medical supply initiative. All bidders must ensure full compliance with federal pharmaceutical and defense packaging regulations, and deliveries must be timed to meet operational readiness schedules at the specified location.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Medical and Pharmaceutical Packaging and Marking ServicesThe contract seeks to provide packaging, labeling, and marking services for pharmaceutical and medical supplies in strict compliance with Medical Marking Standard No. 1 and MIL-STD-2073-1E, ensuring all documentation, markings, and packaging meet federal military and healthcare requirements. Services must be performed at the designated place of performance in Williamsburg, Virginia, with ZIP code 23185, and the work falls under NAICS code 325412, which classifies pharmaceutical and medicine manufacturing. This is a subcontract opportunity issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with a response deadline of August 11, 2026, and posted on August 5, 2026. All submissions must adhere to the stringent standards governing the handling and presentation of medical and pharmaceutical items for defense logistics, and bidders are expected to demonstrate proven expertise in defense-compliant packaging procedures.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Veterinary Pharmaceutical Tablet SupplierThe contract requires the manufacture and supply of Maropitant Citrate 160mg veterinary tablets packaged in blister packs containing four tablets per sheet, fully compliant with FDA and Defense Logistics Agency specifications. The product must meet all regulatory and quality standards for veterinary use, with strict adherence to packaging, labeling, and stability requirements to ensure efficacy and safety during storage and transport. The supplier is expected to deliver consistent, high-quality output in accordance with pharmaceutical manufacturing best practices, and all materials must be traceable and documented to support federal procurement compliance. This subcontract is issued under the Medical Supply Chain Pharm FSA, a division of the Department of Defense, with performance required at the APO ZIP code 09227-0000. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026, indicating a tight turnaround for proposals. The NAICS code 325412 identifies this as a pharmaceutical and biological product manufacturing contract, emphasizing the technical and regulatory expertise necessary for participation. While no set-aside details are provided, the contract is open to qualified subcontractors capable of meeting DoD’s stringent pharmaceutical supply chain requirements, with all deliverables aligned to ensure uninterrupted availability of critical veterinary medications for military and associated personnel.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply – Praziquantel and PyrantelThe contract is for the supply of Praziquantel and Pyrantel in bulk tablet form, identified by NSN 6509015787110, ensuring full compliance with military and federal pharmaceutical standards. This procurement is issued as a subcontract under the Department of Defense, specifically managed by the Medical Supply Chain Pharm FSA, with performance required at APO 09227-0000. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026, with the NAICS code 325412 indicating classification under pharmaceutical and botanical manufacturing. The product must meet stringent quality and regulatory benchmarks to support military medical operations, and all deliveries are expected to adhere to the timelines and specifications outlined by the contracting authority.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Sunscreen Formulation and Manufacturing

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Supply and Packaging

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Nonoxynol-9 Spermicide Formulation and SupplyThe contract outlines the supply of pharmacologically compliant Nonoxynol-9 spermicide specifically formulated for use in lubricated condoms, ensuring it meets all required safety, stability, and human use standards. The product must be manufactured and delivered in full compliance with regulatory specifications to guarantee effectiveness and compatibility with condom materials under varying environmental conditions. The subcontract is issued under the NAICS code 325412, indicating it pertains to pharmaceutical and medicinal product manufacturing, and is managed by the Department of Defense through its Medical Supply Chain division. The solicitation was posted on August 5, 2026, with a strict response deadline of August 11, 2026, leaving a limited window for interested parties to submit proposals. The place of performance is designated as FPO with ZIP code 09588-2304, indicating delivery to a military postal location, likely supporting global defense medical logistics. Although no point of contact or set-aside details are provided, the contract is explicitly classified as a subcontract, meaning it is part of a broader procurement chain managed by a prime contractor under the Department of Defense. All submissions must adhere to the technical and administrative requirements specified in the DIBBS platform listing for SPE2DS26T314B.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Pharmaceutical Manufacturer – Trazodone Tablets (100 mg)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

1 day ago

DEADLINE

in 4 days

View Details

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

NAICS: 541611

New

DIBBS

Export-Controlled Items Compliance (ITAR/EAR)

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Cybersecurity Compliance for Covered Defense Information (CDI)

Computer Systems Design Services

POSTED

DEADLINE

Hazardous Materials Compliance & Safety Data Management

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Domestic and International Pharmaceutical LogisticsThis contract facilitates the domestic and international transportation of pharmaceuticals under FOB Destination terms to Joint Region Marianas, GU, with mandatory climate-controlled shipping options to ensure the integrity of temperature-sensitive medications. Delivery confirmation is required upon completion, ensuring accountability and traceability throughout the logistics chain. The North American Industry Classification System code 484220 indicates the focus on general freight trucking, specifically for specialized cargo such as pharmaceuticals. The solicitation is issued by the Department of Defense under the Medical Supply Chain Pharm FSA, with performance occurring at a military postal address in APO, ZIP 96543-4010. The opportunity is structured as a subcontract with a response deadline of August 11, 2026, and was posted on August 5, 2026, indicating a narrow window for interested parties to submit proposals. Specific contact details and set-aside information are not provided, and bidders must rely on the official DIBBS platform link for full solicitation documentation.

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Medical Item Labeling and Marking (MMS No. 1 Compliance)The contract requires precise labeling of medical items in full compliance with Medical Marking Standard No. 1A, ensuring complete traceability through the inclusion of NSN, CAGE code, lot number, and expiration date on each label. This work is critical for maintaining supply chain integrity across Department of Defense medical logistics and must be executed with strict adherence to the published marking standards. The subcontract is issued under NAICS code 323111 and is intended for performance at APO, zip code 96543-4010, with a response deadline of August 11, 2026, and was posted on August 5, 2026. The contracting activity is managed under the Medical Supply Chain Pharm FSA, operating within the Department of Defense framework, and all submissions must be directed through the official DIBBS RFQ portal linked in the solicitation.

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Hazardous Materials Labeling and ComplianceThe contract requires strict adherence to OSHA’s Hazard Communication Standard and DFARS requirements for pharmaceutical labeling, ensuring all materials are properly identified, classified, and labeled to communicate chemical hazards accurately. A critical component is the mandatory pre-award submission of labeling for review and approval, which must be completed before any contract award is finalized. Compliance must be maintained throughout the lifecycle of the pharmaceutical products being labeled, with all documentation and procedures aligned to federal regulatory frameworks governing hazardous materials in defense-related supply chains. The subcontract is tied to the Department of Defense’s Medical Supply Chain Pharm FSA and specifies APO 96543-4010 as the place of performance, indicating logistics and labeling operations are expected to support military medical logistics globally. The NAICS code 541690 classifies the work under other scientific and technical consulting services, reflecting the specialized nature of regulatory compliance and labeling expertise required. The response deadline is August 11, 2026, with the solicitation posted on August 5, 2026, leaving a limited window for qualified vendors to submit proposals through the DIBBS system. All submissions must demonstrate proven capability in navigating both occupational safety and defense acquisition regulations.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Medical Packaging and Preservation ServicesThe contract entails the commercial and export-grade packaging of pharmaceutical units in sealed, protective containers that adhere to MIL-STD-2073-1E standards and military preservation requirements, ensuring long-term stability and integrity under harsh logistical conditions. The work requires strict compliance with defense-grade packaging protocols to safeguard sensitive medical products throughout storage and transit, particularly for deployment in austere or remote environments. Packaging must be designed to withstand extended periods, extreme temperatures, humidity, and physical stress while maintaining sterility and labeling accuracy. This subcontract is issued by the Department of Defense through the Medical Supply Chain Pharm FSA, with performance to be conducted at APO, ZIP 96543-4010. The solicitation was posted on August 5, 2026, and responses are due by August 11, 2026. The NAICS code 326199 indicates it falls under other plastics product manufacturing, reflecting the specialized nature of the protective packaging materials involved. The scope is focused on end-to-end packaging services tailored to military medical supply chains, with no set-aside provisions indicated, meaning any qualified contractor may bid, and the expectation is on technical precision, certification compliance, and adherence to military preservation norms.

All Other Plastics Product Manufacturing

POSTED

DEADLINE

Packaging, Preservation & LogisticsThe contract requires the provision of military-compliant packaging, preservation, and logistics services for medical supplies, ensuring all items meet stringent shelf-life and transportation standards as dictated by defense protocols. All components must be prepared and handled to maintain integrity during transit and storage, with strict adherence to military specifications for environmental resilience, tamper-evident sealing, and labeling requirements. The work must support the operational readiness of military medical units by guaranteeing that supplies arrive in fully functional, sterile, and date-valid condition regardless of deployment location or environmental conditions. Performance is centered at Fort Drum, New York, with the delivery schedule and quality controls tightly linked to the Department of Defense’s Medical Supply Chain Pharm FSA requirements. Subcontractors must demonstrate proven capability in handling sensitive medical inventory under military-grade logistics frameworks, including compliance with NAICS code 493190 for other warehousing and storage activities. Responses are due by August 11, 2026, and the opportunity is structured as a subcontract under a broader defense procurement effort. All proposals must align with the DLA’s DIBBS system, and successful bidders will be expected to maintain continuous compliance with defense logistics protocols throughout the contract term.

Other Warehousing and Storage

POSTED

DEADLINE

Regulatory Compliance & Labeling ServicesThe contract seeks a subcontractor to prepare and submit hazard communication labels, safety data sheets, and related regulatory documentation in accordance with OSHA, FDA, and DLA standards, ensuring full compliance with federal safety and labeling requirements for medical supply chain operations. The work is tied to the Department of Defense’s Medical Supply Chain Pharm FSA and must be performed at Fort Drum, New York, with an zip code of 13602-5004, indicating the physical location where deliverables are to be managed or coordinated. The solicitation is classified under NAICS code 541690, which covers other scientific and technical consulting services, emphasizing the technical and compliance-oriented nature of the tasks. All proposals must be submitted by August 11, 2026, with the solicitation posted on August 5, 2026, providing a six-day window for responses. The contract is structured as a subcontract, meaning the awarded entity will work under a prime contractor or larger program rather than directly with the government agency. There is no set-aside designation specified, so all eligible businesses may compete regardless of size or ownership status. The official solicitation is accessible via the DIBBS platform using the provided link, and while no point of contact is listed, potential bidders must ensure all submitted materials meet the precise regulatory frameworks governing hazardous material documentation for military and medical use.

Other Scientific and Technical Consulting Services

POSTED

1 day ago

DEADLINE

in 4 days

View Details